The use of chitosan-6-mercaptonicotinic acid nanoparticles for oral peptide drug delivery.

Millotti, Gioconda; Perera, Glen; Vigl, Claudia; Pickl, Karin; Sinner, Frank Michael; Bernkop-Schnürch, Andreas

Millotti, Gioconda; Perera, Glen; Vigl, Claudia; Pickl, Karin; Sinner, Frank Michael; Bernkop-Schnürch, Andreas.

Affiliation

Millotti G; University of Innsbruck, Pharmaceutical Technology, Innrain 52c, Innsbruck, 6020 Austria.

Drug Deliv ; 18(3): 190-7, 2011 Apr.

Article in En | MEDLINE | ID: mdl-21039318

Subject(s)

Chitosan/analogs & derivatives; Chitosan/chemistry; Insulin/administration & dosage; Nanoparticles; Sulfhydryl Compounds/chemistry; Adhesiveness; Administration, Oral; Animals; Area Under Curve; Caco-2 Cells; Chitosan/toxicity; Drug Carriers/chemistry; Drug Carriers/toxicity; Drug Delivery Systems; Drug Stability; Enzyme-Linked Immunosorbent Assay; Humans; Insulin/pharmacokinetics; Insulin/toxicity; Male; Particle Size; Rats; Rats, Sprague-Dawley; Sulfhydryl Compounds/toxicity

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sulfhydryl Compounds / Chitosan / Nanoparticles / Insulin Type of study: Prognostic_studies Limits: Animals / Humans / Male Language: En Journal: Drug Deliv Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2011 Document type: Article Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google